Responses
Global health
Original research
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 3 August 2022